Extranodal T-cell/histiocyte-rich large C-cell lymphoma presenting primarily on the skin

Acta Dermato-Venereologica

Volumn 92, Issue 6, 2012, Pages 637-639

  Kambayashi, Yumi ^a   Fujimura, Taku ^a   Tsukada, Akira ^a   Hashimoto, Akira ^a   Aiba, Setsuya ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULYSIN;

ADULT; B CELL LYMPHOMA; CANCER INFILTRATION; CANCER PROGNOSIS; CANCER STAGING; CASE REPORT; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN HEAVY CHAIN GENE; IMMUNOHISTOCHEMISTRY; LETTER; MALE; PRIORITY JOURNAL; RARE DISEASE; SKIN BIOPSY; SKIN LYMPHOMA; SOUTHERN BLOTTING; T CELL HISTIOCYTE RICH LARGE B CELL LYMPHOMA;

ADULT; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; DERMATOLOGIC SURGICAL PROCEDURES; HISTIOCYTES; HUMANS; LYMPHOCYTES, TUMOR-INFILTRATING; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; RADIOTHERAPY, ADJUVANT; SKIN; SKIN NEOPLASMS; T-LYMPHOCYTES; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84867838199     PISSN: 00015555     EISSN: 16512057     Source Type: Journal    
DOI: 10.2340/00015555-1435     Document Type: Letter

References (10)

1. Vezzoli P, Fiorani R, Girgenti V, Fanoni D, Tavecchio S, Balice Y, et al. title typecontributorCutaneous T- cell/histiocyte-rich B cell lymphoma: a case report and review of the literature/title. Dermatology 2011; 222: 225-230.
2. Krensky AM, Clayberger C. Granulysin: a novel host defense molecule. Am J Transplant 2005; 5: 1789-1792.
3. Deng A, Chen S, Li Q, Lyu S-C, Clayberger C, Krensky AM. Granulysin, a cytolytic molecule, is also chemoattractant and proinflam-matory activator. J Immunol 2005; 174: 5243-5248.
4. Kodama K, Massone C, Chott A, Metze D, Kerl H, Cerroni L. Primary cutaneous large B-cell lymphomas: clinicopathologic features, classification, and prognostic factors in a large series of patients. Blood 2005; 106: 2491-2497.
5. Pagès F, Berger A, Camus M, Sanchez-Cabo F, Costes A, Molidor R, et al. Effectors memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med 2005; 353: 2654-2666.
6. Kitamura N, Katagiri YU, Itagaki M, Miyagawa Y, Onda K, Okita H, et al. The expression of granulysin in systemic anaplastic large cell lymphoma in childhood. Leuk Res 2009; 33: 908-912.
7. Fujimura T, Mahnke K, Enk AH. Myeloid derived suppressor cells and their role in tolerance induction in cancer. J Dermatol Sci 2010; 59: 1-6.
8. Fujimura T, Okuyama R, Ito Y, Aiba S. Profiles of Foxp3+ regulatory T cells in eczematous dermatitis, psoriasis vulgaris and mycosis fungoides. Br J Dermatol 2008; 158: 1256-1263.
9. Viguier M, Lemaître F, Verola O, Cho MS, Gorochov G, Dubertret, et al. Foxp3 expression CD4+CD25high regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells. J Immmunol 2004; 173: 1444-1453.
10. Felcht M, Heck M, Weiss C, Becker JC, Dippel E, Müller CS, et al. Expression of the T-cell regulatory marker FOXP3 in primary cutaneous large B-cell lymphoma tumor cells. Br J Dermatol 2012; 167: 348-358.